Richard Gonzalez, AbbVie CEO (Chris Kleponis/picture-alliance/dpa/AP Images)
House committee to grill AbbVie CEO next month on suppressing Humira competition
AbbVie CEO Richard Gonzalez will be in the hot seat on May 18, again defending the company’s mammoth blockbuster drug Humira before the House Oversight Committee as competition for the world’s best-selling drug isn’t likely to hit American shores for about two years.
Oversight Committee Chairwoman Carolyn Maloney (D-NY) has been zeroing in on AbbVie for months now, even threatening to issue a subpoena last September for documents as part of her committee’s ongoing investigation into drug pricing practices.
To read Endpoints News become a free subscriber
Unlock this article instantly, along with access to limited free monthly articles and our suite of newsletters